Clinical Trials in Salt Lake City

Showing 12061-12080 of 14,325 trials

Efficacy of Provex CV Supplement to Reduce Inflammation Cytokines and Blood Pressure

NCT01106170

The purpose of this study is to determine if a supplement called Provex CV can reduce blood pressure and other risk factors for heart disease. Heart disease is the leading cause of death in this country and it is important to identify dietary factors, including supplements, that can reduce heart disease risk factors. The supplement to be tested in this study is made of a combination of natural compounds found in plants such as grapeseed extract, green tea, and quercetin. Each compound individually has been shown to improve blood pressure or reduce inflammation. We hypothesize that Provex CV will reduce blood pressure and levels of inflammatory cytokines hypertensive patients with symptoms of metabolic syndrome. This investigational trial of Provex CV has been approved by the United States Food and Drug Administration.

Blood Pressure

University of Utah20 participantsStarted Mar 2010

Salt Lake City, Utah, United States

COMPLETEDPhase 2/3< 1 mile

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

NCT01530763

This is a study of safety and effectiveness of ceftaroline fosamil in children with Community Acquired Bacterial Pneumonia receiving antibiotic therapy in the hospital.

InfectionsCommunity Acquired Pneumonia

Forest Laboratories161 participantsStarted Sep 2012

Long Beach, California, United States • Oakland, California, United States • Orange, California, United States +41 more locations

Efficacy of Provex CV Supplement to Reduce Inflammation Cytokines and Blood Pressure

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

Find Trials by Condition in Salt Lake City

A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome

MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer

A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.

A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia

Identification of a Plasma Proteomic Signature for Lung Cancer

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics

A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis

Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer

Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy

Treatment of Subcutaneous Adipose Tissue in the Thighs Using High Intensity Focused Ultrasound

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections

A Study of DER 45-EV Gel to Treat Rosacea

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer

RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care

Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease